Acasă › Cancer pancreatic › North Carolina › Durham
Studii clinice pentru Cancer pancreatic în Durham, NC
24 studii pentru Cancer pancreatic caută participanți în și în jurul orașului Durham (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
The Vanguard Study: Testing a New Way to Screen for Cancer
În curs de recrutareVoluntari sănătoși bineveniți
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
A Study of PHN-012 in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1
- PHN-012-001 Site, Durham
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
În curs de recrutareFaza 3
- Duke Cancer Center, Durham
DESTINY-PANTUMOUR04
În curs de recrutareStudiu observațional
- Research Site, Durham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
În curs de recrutareFaza 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · La 10 mi distanță
- University of North Carolina Hospitals at Hillsborough, Hillsborough · La 13 mi distanță
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
În curs de recrutareFaza 3
- Duke Cancer Center, Durham
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
În curs de recrutareFaza 3
- Investigative Site US035, Chapel Hill · La 10 mi distanță
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
În curs de recrutareFaza 1/2
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
În curs de recrutareFaza 2
- Local Institution - 0100, Durham
Promoting CT Engagement for Pancreatic Cancer With App
În curs de recrutare
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
În curs de recrutareStudiu observațional
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
- University of North Carolina-Hillsborough Campus, Hillsborough · La 13 mi distanță
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
În curs de recrutareFaza 2
- University of North Carolina, Chapel Hill · La 10 mi distanță
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
În curs de recrutareFaza 1
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill · La 10 mi distanță
- University of North Carolina, Chapel Hill · La 10 mi distanță
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
În curs de recrutareFaza 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
În curs de recrutareFaza 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
În curs de recrutareFaza 2
- Duke University Medical Center, Durham
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
În curs de recrutareFaza 1
- Duke Cancer Institute /ID# 276267, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
În curs de recrutareFaza 1
- Research Site, Durham
Autologous CAR-T Cells Targeting B7-H3 in PDAC
În curs de recrutareFaza 1
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
În curs de recrutareFaza 1
- Duke Cancer Center, Durham
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
În curs de recrutareFaza 1/2
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
În curs de recrutareFaza 2
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Chapel Hill · La 10 mi distanță
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
În curs de recrutareFaza 2
- University of North Carolina, Chapel Hill · La 10 mi distanță
Studii pentru Cancer pancreatic în alte orașe
- Houston, TX61 studii
- New York City, NY60 studii
- Boston, MA43 studii
- Nashville, TN39 studii
- Los Angeles, CA35 studii
- St. Louis, MO33 studii
- Arlington, VA33 studii
- Baltimore, MD31 studii
- San Antonio, TX31 studii
- Philadelphia, PA26 studii
- Tampa, FL26 studii
- San Diego, CA24 studii
Alte studii în Durham
- Cancer de sân64 studii
- Cancer (toate tipurile)58 studii
- Cancer pulmonar cu celule non-pătrate39 studii
- Mielom multiplu37 studii
- Leucemie mieloasă acută33 studii
- Cancer metastatic33 studii
- Cancer de prostată32 studii
- Cancer pulmonar32 studii
- Cancer colorectal28 studii
- Cancer ovarian27 studii
- Leucemie limfatică cronică27 studii
- Insuficiență cardiacă26 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.